These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 7025285
41. [Effect of various chemotherapeutic agents on the synthesis and distribution of DNA in human strains of kidney and lung cancer, melanoma and Ewing's sarcoma transplanted to athymic mice]. Revazova ES, Petrova AS, Iudicheva TV, Zubrikhina TN. Biull Eksp Biol Med; 1981 Oct; 91(10):471-3. PubMed ID: 7317610 [No Abstract] [Full Text] [Related]
42. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878). Burke PJ, Owens AH, Colsky J, Shnider BI, Edmonson JH, Schilling A, Brodovsky HS, Wallace HJ, Hall TC. Cancer Res; 1970 May; 30(5):1512-5. PubMed ID: 5426952 [No Abstract] [Full Text] [Related]
43. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice. Ananda S, Field KM, Kosmider S, Compston D, Desai J, Lim LC, Barnett FS, Jones IT, Skinner I, Gibbs P. J Clin Oncol; 2008 Sep 20; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167 [No Abstract] [Full Text] [Related]
44. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). Gottlieb JA, Guarino AM, Call JB, Oliverio VT, Block JB. Cancer Chemother Rep; 1970 Dec 20; 54(6):461-70. PubMed ID: 4946015 [No Abstract] [Full Text] [Related]
47. New approaches in administration of anticancer drugs. Rall DP. Cancer Res; 1969 Dec 20; 29(12):2471-4. PubMed ID: 5369694 [No Abstract] [Full Text] [Related]
48. Adjuvant interferon in melanoma - a resurrection? Middleton MR, Thatcher N. Br J Cancer; 2001 May 04; 84(9):1141-2. PubMed ID: 11336461 [No Abstract] [Full Text] [Related]
52. [Management of non-small-cell bronchial cancers. Which chemotherapy for a stage IV?]. Quoix E. Rev Mal Respir; 1999 Jan 04; 16 Suppl 3():S122-5. PubMed ID: 10088281 [No Abstract] [Full Text] [Related]
53. [Mono- and poly-chemotherapy, adjuvant chemotherapy, and combined treatments of cancers in adults]. Jallut O. Rev Med Suisse Romande; 1976 Nov 04; 96(11):839-48. PubMed ID: 1005989 [No Abstract] [Full Text] [Related]
54. Preliminary observations on the Ledakrin effects in treatment of patients with lung carcinoma. Kwasniewska-Rokicińska C, Swiecki J, Drosik K. Mater Med Pol; 1976 Nov 04; 8(3):289-94. PubMed ID: 1011871 [No Abstract] [Full Text] [Related]
55. [A clinico-experimental study in metronomic therapy of disseminated solid tumors]. Chudenko VA, Moiseenko VM. Vopr Onkol; 2009 Nov 04; 55(3):327-34. PubMed ID: 19670733 [Abstract] [Full Text] [Related]
56. Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: clinical trials. Carbone PP. Cancer Chemother Rep 3; 1972 May 04; 3(1):73-5. PubMed ID: 4559007 [No Abstract] [Full Text] [Related]
57. Some preliminary observations during the phase I clinical testing of cis-dichlorodiammineplatinum. II. Fiserová J, Dostálová O, Drobník J, Dohnalová J, Holík F. Neoplasma; 1973 May 04; 20(2):221-2. PubMed ID: 4707844 [No Abstract] [Full Text] [Related]
58. The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine. Sullivan RD, Miller E. Cancer Res; 1965 Aug 04; 25(7):1025-33. PubMed ID: 4284747 [No Abstract] [Full Text] [Related]
59. [Transition of criteria for the determination of efficacy of cancer chemotherapy]. Koyama Y. Gan To Kagaku Ryoho; 1986 Jan 04; 13(1):153-63. PubMed ID: 3942397 [No Abstract] [Full Text] [Related]
60. Prednisolone in terminal breast and bronchogenic cancer. Twycross RG, Guppy D. Practitioner; 1985 Jan 04; 229(1399):57-9. PubMed ID: 2581241 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]